Liposomal latanoprost
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
148
NCT02466399
POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2015
Completion: Apr 30, 2016
NCT02599688
Open Label Extension of LipoLat-CS202
Phase: N/A
Start: Nov 30, 2015
Completion: Jun 30, 2016
NCT05935527
Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon
Phase: Phase 1
Start: Apr 28, 2023
Completion: Nov 18, 2024
Loading map...